Construction of plasmids expressing Sars-CoV encoding proteins and their effects on transcription of hfgl2 prothrombinase

Abstract

SARS coronavirus (SARS-CoV) is the etiologic agent of severe acute respiratory syndrome. The aim of this study was to construct Sars-CoV membrane (M), nucleocapsid (N) and spike 2 (S2) gene eukaryotic expression plasmids, and identify their expression in vitro. Gene fragments encoding N protein, M protein and S2 protein of SARS-CoV were amplified by PCR using cDNA obtained from lung samples of SARS patients as template, and subcloned into pcDNA3.1 vector to form eukaryotic expression plasmids. SARS-CoV protein eukaryotic expression plasmids were transfected respectively into CHO cells. Immunohistochemistry was employed to detect the expression of the structural proteins of SARS-CoV in transfected cells. SARS-CoV protein eukaryotic expression plasmids were successfully constructed by identification with digestion of restriction enzymes and sequencing. M, N and S2 proteins of SARS-CoV were detected in the cytoplasm of transfected CHO cells. It was concluded that these recombinant eukaryotic expression plasmids were constructed successfully, and SARS-CoV encoding proteins could activate transcription and expression of hfgl2 gene.

References

[1] DrostenC., GuntherS., PreiserW., et al.. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med, 2003, 348: 1967-1976

[2] MarraM.A., JonesS.J., AstellC.R., et al.. The Genome sequence of the SARS-associated coronavirus. Science, 2003, 300: 1399-1404

[3] RotaP.A., ObersteM.S., MonroeS.S., et al.. Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science, 2003, 300: 1394-1399

[4] HeY., ZhouY., WuH., et al.. Mapping of antigenic sites on the nucleocapsid protein of the severe acute respiratory syndrome coronavirus. J Clin Microbiol, 2004, 42: 5309-5314

[5] HuY., WenJ., TangL., et al.. The M Protein of SARS-CoV: Basic structural and immunological properties. Genom Proteom Bioinform, 2003, 1: 118-130

[6] ChenH., WurmT., BrittonP., et al.. Interaction of the coronavirus nucleoprotein with nucleolar antigens and the host cell. J Viro, 2002, 76: 5233-5250

[7] LiaoQ.J., YeL.B., TimaniK.A., et al.. Activation of NF-kappaB by the full-length nucleocapsid protein of the SARS coronavirus. Acta Biochim Biophys Sin (Chinese), 2005, 37: 607-612

[8] YanX., HaoQ., MuY., et al.. Nucleocapsid protein of SARS-CoV activates the expression of cyclooxygenase-2 by binding directly to regulatory elements for nuclear factor-kappa B and CCAAT/enhancer binding protein. Int J Biochem Cell Biol, 2006, 38: 1417-1428

[9] LawH.K., CheungC.Y., NgH.Y., et al.. Chemokine up-regulation in SARS-coronavirus-infected, monocyte-derived human dendritic cells. Blood, 2005, 106: 2366-2374

[10] SurjitM., LiuB., JameelS., et al.. The SARS coronavirus nucleocapsid protein induces actin reorganization and apoptosis in COS-1 cells in the absence of growth factors. Biochem J, 2004, 383(Pt1): 13-18

[11] ZhuC.L., YanW.M., ZhuF., et al.. Fibrinogen-like protein 2 fibroleukin expression and its correlation with disease progression in murine hepatitis virus type 3-induced fulminant hepatitis and in patients with severe viral hepatitis B. World J Gastroenterol, 2005, 11: 6936-6940

[12] DingJ.W., NingQ., LiuM.F., et al.. Expression of the fgl2 and its protein product (prothrombinase) in tissues during murine hepatitis virus strain-3 (MHV-3) infection. Adv Exp Med Biol, 1998, 440: 609-618

[13] LevyG.A., LiuM., DingJ., et al.. Molecular and functional analysis of the human prothrombinase gene (HFGL2) and its role in viral hepatitis. Am J Pathol, 2000, 156: 1217-1225

[14] NingQ., LiuM., KongkhamP., et al.. The nucleocapsid protein of murine hepatitis virus type 3 induces transcription of the novel fgl2 prothrombinase gene. J Biol Chem, 1999, 274: 9930-9936

[15] MarazziS., BlumS., HartmannR., et al.. Characterization of human fibroleukin, a fibrinogen-like protein secreted by T lymphocytes. J Immunol, 1998, 161: 138-147

[16] MarsdenP.A., NingQ., FungL.S., et al.. The Fgl2/fibroleukin prothrombinase contributes to immunologically mediated thrombosis in experimental and human viral hepatitis. J Clin Invest, 2003, 112: 58-66

[17] NingQ., SunY., HanM., et al.. Role of fibrinogen-like protein 2 prothrombinase/fibroleukin in experimental and human allograft rejection. J Immunol, 2005, 174: 7403-7411

[18] RobertsonM.. Fgl2: link between hepatitis B and SARS. Drug Discov Today, 2003, 8: 768-770

[19] YanW.M., NingQ., LuoX.P.. Liver impairment in MHV-3 induced murine SARS model. Chin J Infect Dis (Chinese), 2006, 24: 361-365

[20] MaS.W., WangZ.H., ZhangK., et al.. Expression of recombinant SARS associated coronavirus structural protein in Escherchiacoli BL21. Med J Chin PLA (Chinese), 2004, 29: 748-751

[21] PeiF., ZhengJ., GaoZ.F., et al.. Lung pathology and pathogenesis of severe acute respiratory syndrome: a report of six full autopsies. Chin J Pathol (Chinese), 2005, 34: 656-660

[22] Yan WM, Zhu CL, Luo XP, et al. Establishment of a substitutive SARS murine model and its application in SARS study. J Clin Immunol (Chinese), 2005,Supplement(1):166–167

[23] NingQ., LakatooS., LiuM., et al.. Induction of prothrombinase fgl2 by the nucleocapsid protein of virulent mouse hepatitis virus is dependent on host hepatic nuclear factor-4 alpha. J Biol Chem, 2003, 278: 15 541-15 549

[24] HeR., LeesonA., AndonovA., et al.. Activation of AP-1 signal transduction pathway by SARS coronavirus nucleocapsid protein. Biochem Biophys Res Commun, 2003, 311: 870-876

[25] Opecky-BrombergS.A., Martinez-SobridoL., PaleseP., et al.. 7a protein of severe acute respiratory syndrome coronavirus inhibits cellular protein synthesis and activates p38 mitogen-activated protein kinase. J Virol, 2006, 80: 785-793

[26] AiC.W., ChanZ.R., YangD.G., et al.. Accelerated induction of apoptosis in insect cells by baculovirus-expressed SARS-CoV membrane protein. FEBS Lett, 2006, 580: 3829-3834

RIGHTS & PERMISSIONS

Huazhong University of Science and Technology and Springer-Verlag GmbH